Comerica Bank’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $78.8M | Buy |
161,683
+3,731
| +2% | +$1.74M | 0.31% | 55 |
|
|
2025
Q3 | $66.2M | Sell |
157,952
-4,028
| -2% | -$1.35M | 0.25% | 68 |
|
|
2025
Q2 | $46.5M | Sell |
161,980
-22,623
| -12% | -$6.76M | 0.18% | 106 |
|
|
2025
Q1 | $56.9M | Buy |
184,603
+9,956
| +6% | +$3.41M | 0.24% | 75 |
|
|
2024
Q4 | $61.6M | Buy |
174,647
+4,352
| +3% | +$1.6M | 0.25% | 68 |
|
|
2024
Q3 | $61M | Buy |
170,295
+9,430
| +6% | +$3.19M | 0.24% | 74 |
|
|
2024
Q2 | $51.2M | Sell |
160,865
-5,046
| -3% | -$1.34M | 0.21% | 84 |
|
|
2024
Q1 | $38.1M | Buy |
165,911
+9,244
| +6% | +$2.09M | 0.16% | 116 |
|
|
2023
Q4 | $34.4M | Buy |
156,667
+80
| +0.1% | +$18.4K | 0.16% | 119 |
|
|
2023
Q3 | $35.4M | Buy |
156,587
+150,989
| +2,697% | +$34.8M | 0.18% | 98 |
|
|
2023
Q2 | $2 | Buy |
+5,598
| New | +$1.24M | ﹤0.01% | 606 |
|
|
2022
Q4 | $7.04M | Sell |
26,967
-1,176
| -4% | -$297K | 0.05% | 412 |
|
|
2022
Q3 | $6.25M | Sell |
28,143
-169
| -0.6% | -$37.8K | 0.05% | 404 |
|
|
2022
Q2 | $6.55M | Sell |
28,312
-1,898
| -6% | -$386K | 0.05% | 401 |
|
|
2022
Q1 | $5.66M | Buy |
30,210
+2,026
| +7% | +$386K | 0.04% | 519 |
|
|
2021
Q4 | $5.63M | Sell |
28,184
-32,952
| -54% | -$6.47M | 0.04% | 513 |
|
|
2021
Q3 | $12M | Buy |
61,136
+27,891
| +84% | +$5.49M | 0.07% | 281 |
|
|
2021
Q2 | $6.68M | Sell |
33,245
-131
| -0.4% | -$24.9K | 0.04% | 544 |
|
|
2021
Q1 | $6.92M | Sell |
33,376
-332
| -1% | -$55.4K | 0.04% | 544 |
|
|
2020
Q4 | $5.65M | Buy |
33,708
+5,862
| +21% | +$769K | 0.04% | 623 |
|
|
2020
Q3 | $3.42M | Sell |
27,846
-457
| -2% | -$50.1K | 0.02% | 783 |
|
|
2020
Q2 | $3.21M | Buy |
28,303
+2,656
| +10% | +$299K | 0.02% | 764 |
|
|
2020
Q1 | $2.85M | Sell |
25,647
-85
| -0.3% | -$8.08K | 0.03% | 703 |
|
|
2019
Q4 | $2.48M | Buy |
25,732
+256
| +1% | +$22.5K | 0.02% | 987 |
|
|
2019
Q3 | $2.12M | Buy |
25,476
+28
| +0.1% | +$2.25K | 0.02% | 1052 |
|
|
2019
Q2 | $1.94M | Sell |
25,448
-2,748
| -10% | -$257K | 0.02% | 1112 |
|
|
2019
Q1 | $3.12M | Sell |
28,196
-302
| -1% | -$35.2K | 0.03% | 807 |
|
|
2018
Q4 | $3.31M | Buy |
28,498
+468
| +2% | +$54.3K | 0.03% | 748 |
|
|
2018
Q3 | $3.49M | Sell |
28,030
-5,260
| -16% | -$651K | 0.03% | 743 |
|
|
2018
Q2 | $4.12M | Sell |
33,290
-786
| -2% | -$86.4K | 0.03% | 760 |
|
|
2018
Q1 | $3.85M | Sell |
34,076
-23
| -0.1% | -$2.92K | 0.03% | 804 |
|
|
2017
Q4 | $4.72M | Buy |
34,099
+56
| +0.2% | +$7.12K | 0.03% | 708 |
|
|
2017
Q3 | $4.08M | Sell |
34,043
-1,206
| -3% | -$154K | 0.03% | 737 |
|
|
2017
Q2 | $4.63M | Buy |
35,249
+458
| +1% | +$57.1K | 0.03% | 621 |
|
|
2017
Q1 | $4.19M | Buy |
34,791
+3,228
| +10% | +$489K | 0.03% | 697 |
|
|
2016
Q4 | $4.74M | Buy |
31,563
+1,148
| +4% | +$147K | 0.04% | 595 |
|
|
2016
Q3 | $3.69M | Sell |
30,415
-486
| -2% | -$58.4K | 0.03% | 676 |
|
|
2016
Q2 | $3.87M | Buy |
30,901
+330
| +1% | +$36.8K | 0.03% | 616 |
|
|
2016
Q1 | $3.53M | Sell |
30,571
-1,025
| -3% | -$130K | 0.03% | 653 |
|
|
2015
Q4 | $4.47M | Sell |
31,596
-32
| -0.1% | -$4.66K | 0.04% | 490 |
|
|
2015
Q3 | $4.15M | Sell |
31,628
-32,324
| -51% | -$5.18M | 0.04% | 536 |
|
|
2015
Q2 | $11.1M | Buy |
63,952
+31,547
| +97% | +$5.67M | 0.05% | 432 |
|
|
2015
Q1 | $5.59M | Sell |
32,405
-33,881
| -51% | -$5.17M | 0.05% | 416 |
|
|
2014
Q4 | $8.58M | Buy |
66,286
+32,111
| +94% | +$4.14M | 0.04% | 540 |
|
|
2014
Q3 | $4.4M | Buy |
34,175
+2,773
| +9% | +$286K | 0.04% | 530 |
|
|
2014
Q2 | $2.78M | Sell |
31,402
-5,194
| -14% | -$499K | 0.02% | 883 |
|
|
2014
Q1 | $3.44M | Sell |
36,596
-12,982
| -26% | -$1.33M | 0.03% | 773 |
|
|
2013
Q4 | $5.61M | Sell |
49,578
-65,011
| -57% | -$5.86M | 0.04% | 469 |
|
|
2013
Q3 | $9.04M | Buy |
+114,589
| New | +$8.38M | 0.06% | 307 |
|
Other funds holding UTHR
ACA
Comerica Bank's UTHR Position: Q4 2025 in Review
Comerica Bank increased its United Therapeutics (UTHR) stake by 2.4% in Q4 2025, buying an estimated $1.74M and bringing the position to 161,683 shares worth $78.8M. The position accounts for 0.31% of the portfolio, ranked #55.
Comerica Bank first reported a position in UTHR in Q3 2013 and has held it in 49 quarters since. 837 funds tracked by Wall St. Rank hold UTHR as of Q4 2025.
- Comerica Bank held 161,683 shares of United Therapeutics worth $78.8M as of Q4 2025.
- Comerica Bank bought 3,731 United Therapeutics shares in Q4 2025, an estimated $1.74M.
- United Therapeutics made up 0.31% of Comerica Bank's portfolio in Q4 2025, its #55 holding.
- Comerica Bank first reported a position in United Therapeutics in Q3 2013 and has held it in 49 quarters since.
- 837 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2025.
Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.